Kidney and liver fat accumulation: from imaging to clinical consequences

[11] Kaya E(2012)Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans Br J Radiol 48 1005-855

[12] Yilmaz Y(2022)Diagnostic performance of hypoechoic perinephric fat as a predictor of prediabetes and diabetes Abdom Radiol (NY). 23 67-3573

[13] Fahed G(2006)Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabet Med 9 692-772

[14] Aoun L(2020)Noninvasive diagnosis of NAFLD and NASH Cells 251 848-790

[15] Bou Zerdan M(2009)Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T Radiology 9 3564-906

[16] Allam S(2016)Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis Therap Adv Gastroenterol 31 763-348

[17] Bou Zerdan M(2016)Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease J Gastroenterol Hepatol 29 784-647

[18] Bouferraa Y(2019)Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis Eur Radiol 68 901-72

[19] Papatheodoridi M(2018)Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials Hepatology 58 340-1782

[20] Cholongitas E(2011)Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study Hypertension 56 641-2081

[11] Kaya E(2012)Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans Br J Radiol 48 1005-855

[12] Yilmaz Y(2022)Diagnostic performance of hypoechoic perinephric fat as a predictor of prediabetes and diabetes Abdom Radiol (NY). 23 67-3573

[13] Fahed G(2006)Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabet Med 9 692-772

[14] Aoun L(2020)Noninvasive diagnosis of NAFLD and NASH Cells 251 848-790

[15] Bou Zerdan M(2009)Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T Radiology 9 3564-906

[16] Allam S(2016)Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis Therap Adv Gastroenterol 31 763-348

[17] Bou Zerdan M(2016)Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease J Gastroenterol Hepatol 29 784-647

[18] Bouferraa Y(2019)Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis Eur Radiol 68 901-72

[19] Papatheodoridi M(2018)Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials Hepatology 58 340-1782

[20] Cholongitas E(2011)Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study Hypertension 56 641-2081